Monika Schmidt

11PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyMajor global burdens of diseaseFree radical chemistryBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 16, 2024
Neuroprotective Effect of 2-(Benzyloxy)arylureas Is Not Related to CypD Inhibition nor Suppression of mPTP Opening.

Annamaria Haleckova, Veronika Syrova, Andrea Joklova

|Dec 20, 2023
Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity.

Michaela Hanzlova, Marketa Sedlacek Miskerikova, Aneta Rotterova

|Jul 17, 2023
Physiologically relevant fluorescent assay for identification of 17β-hydroxysteroid dehydrogenase type 10 inhibitors.

Monika Schmidt, Michaela Vaskova, Aneta Rotterova

|Feb 23, 2022
Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides.

Zuzana Kohoutova, David Malinak, Rudolf Andrys

|Aug 07, 2021
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies.

Abdullah Al Mamun, Filip Pidaný, Daniela Hulcová

|Jan 20, 2021
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates.

Hyun Myung Lee, Rudolf Andrys, Jakub Jonczyk

Pageof 2

Frequent Collaborators

7 joint publications

Kamil Musilek

5 joint publications

Ondrej Benek

3 joint publications

Michaela Vaskova

3 joint publications

Daniel Jun